|
|
||||||||
From the Laboratoire de Génétique des Maladies Vasculaires (Drs. Labauge and Laberge), INSERM EPI 99-21, Faculté de Médecine Lariboisière, Paris; Department of Neurology (Dr. Labauge), CHU de Montpellier-Nîmes, Hôpital Caremeau, Nîmes; Service de Radiologie Adultes Bretonneau (Dr. Brunereau), Tours; and Service de Neurochirurgie (Dr. Houtteville), Caen, France.
Address correspondence and reprint requests to Dr. P. Labauge, Laboratoire de Génétique des Maladies Vasculaires, INSERM EPI 99-21, Faculté de Médecine Lariboisière, 10 Avenue de Verdun 75010, Paris, France; e-mail: labauge{at}hotmail.com
Background: Cerebral cavernous malformation (CCM) is one of the most common vascular malformations of the CNS. Familial CCM are increasingly diagnosed, but little is known about their natural history, especially in asymptomatic patients.
Objective: To determine the degree of spontaneous evolution of familial CCM in a population of 33 symptom-free patients.
Methods: During a previous national survey, the authors analyzed the clinical and MRI features of 173 patients from 57 unrelated French families, including 73 asymptomatic subjects. Of these 73 subjects, 33 prospectively underwent two serial clinical and MRI examinations. Cerebral MRI systematically included spin echo and gradient echo sequences. Occurrence of clinical symptoms and MRI changes of CCM, namely, hemorrhage, change in signal intensity, change in size, and appearance of new lesions, were recorded by means of comparison of the first and last MRI examinations.
Results: The 33 patients (234 CCM, mean 7.1 lesions/subject, range 1 to 85 lesions/subject) were followed during a mean period of 2.1 years (range 0.5 to 4.5 years). Two patients became symptomatic: One presented with brainstem hemorrhage and one with partial seizure. Comparison of the two serial MR images found changes in 15 patients (46%): 1) Bleeding occurred in three type II lesions (1.3%) in three patients (9.1%); 2) 30 new lesions appeared in 10 patients (30.3%); 3) change in signal intensity was observed in one lesion (0.4%) in one patient (3%); and 4) increase in size was observed in four lesions (1.7%) in three patients (9.1%).
Conclusions: This prospective study confirms the dynamic nature of CCM. The appearance of new lesions in 30% of patients has to be retained as a hallmark of the familial condition.
This article has been cited by other articles:
![]() |
R. Al-Shahi Salman, M. J. Berg, L. Morrison, I. A. Awad, and on behalf of the Angioma Alliance Scientific Advis Hemorrhage From Cavernous Malformations of the Brain: Definition and Reporting Standards Stroke, December 1, 2008; 39(12): 3222 - 3230. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stapf and D. Herve From Cavern-Dwellers to Cavernoma Science: Towards a New Philosophy of Cerebral Cavernous Malformations Stroke, December 1, 2008; 39(12): 3129 - 3130. [Full Text] [PDF] |
||||
![]() |
J.M. de Souza, R.C. Domingues, L.C.H. Cruz Jr., F.S. Domingues, T. Iasbeck, and E.L. Gasparetto Susceptibility-Weighted Imaging for the Evaluation of Patients with Familial Cerebral Cavernous Malformations: A Comparison with T2-Weighted Fast Spin-Echo and Gradient-Echo Sequences AJNR Am. J. Neuroradiol., January 1, 2008; 29(1): 154 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Asmus, L. E. Hjermind, E. Dupont, J. Wagenstaller, E. Haberlandt, M. Munz, T. M. Strom, and T. Gasser Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype Brain, October 1, 2007; 130(10): 2736 - 2745. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-G. Lehnhardt, U. von Smekal, B. Ruckriem, W. Stenzel, M. Neveling, W.-D. Heiss, and A. H. Jacobs Value of Gradient-Echo Magnetic Resonance Imaging in the Diagnosis of Familial Cerebral Cavernous Malformation Arch Neurol, April 1, 2005; 62(4): 653 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ikeda, K.-i. Hosozawa, H. Kashihara, S. Kuratomi, J. Kumazawa, M. Shioikari, A. Kuwajima, M. Tamura, and Y. Iwasaki Familial cavernous angiomas Neurology, January 11, 2005; 64(1): 163 - 163. [Full Text] [PDF] |
||||
![]() |
K.-H. Jung, K. Chu, S.-W. Jeong, H.-K. Park, H.-J. Bae, and B.-W. Yoon Cerebral Cavernous Malformations With Dynamic and Progressive Course: Correlation Study With Vascular Endothelial Growth Factor Arch Neurol, November 1, 2003; 60(11): 1613 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Reich, J. Winkler, A. Straube, H.J. Steiger, and A. Peraud Molecular genetic investigations in the CCM1 gene in sporadic cerebral cavernomas Neurology, April 8, 2003; 60(7): 1135 - 1138. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |